Product Description: Sofosbuvir directly targets the Hepatitis C virus to stop it from making copies of itself in the liver. Sofosbuvir attaches itself to the genetic information, called RNA, to block the virus from multiplying. And Daclatasvir is a direct-acting   antiviral agent (DAA) against the hepatitis C virus.

Product Features:

Product Name : Darvoni
Generic Name : Sofosbuvir 400 mg and Daclatasvir 60 mg
Formulation : Tablet
Available Pack Size : 1×6’s
Available Strength : Sofosbuvir 400 mg and Daclatasvir 60 mg
Registrations : Export Only

Categories:    Antiviral, Biotech Products